PerkinElmer (PKI) PT Raised to $175 at Stifel Following EPS and BioLegend Deal
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/20/2026
- Wall Street sinks as bond yields rise, Walmart results disappoint
- Walmart shares fall despite earnings beat
- Alibaba stock dips as Q2 profit misses estimates despite strong AI cloud growth
- Wolfe remains "broadly bullish on AI semis stocks", names Top Pick
- Moderna stock pulls back after massive one-day rally: analysts weigh in
- Marvell issues Google warrant tied to custom chip deal
- FOMC minutes from July 28-29th meeting
- US stock futures steady after tech slump; investors focus on Middle East tensions
- Lowe's Cos. (LOW) Tops Q2 EPS by 17c, Misses on Revenue; Offers Fy27 Guidance
- Wall Street sinks as bond yields rise, Walmart results disappoint
PerkinElmer Announces Financial Results for the Second Quarter of 2021
July 26, 2021 6:31 AM EDTRevenue of $1.228 billion; 51% reported growth; 41% organic growth GAAP EPS from continuing operations of $2.19; Adjusted EPS of $2.83 Initiates Third Quarter and Raises Full-Year Revenue and Earnings Guidance Announces Agreement to Acquire BioLegend Leading Antibody & Research Reagent Provider
Earnings Call Moved to Today at 8:00 a.m. Eastern Time; Dial-in Information Below
WALTHAM, Mass.--(BUSINESS... More
PerkinElmer to Acquire Antibody and Reagent Leader BioLegend
July 26, 2021 6:30 AM EDTTransformative deal significantly scales leading position in life science to accelerate legendary discoveries in precision medicine
Leader in antibody development with highly complementary, innovative portfolio in emerging, high-growth areas of biologics, cell and gene therapy, proteogenomics, and recombinant proteins Commercial synergy opportunity to accelerate life science growth with potential benefits for diagnostics franchise Annual BioLegend revenues of approximately $380 million estimated in 2022 with mid-teens-plus expected revenue growth (excluding synergies) Elevated growth and margin profile for combined company with strong, immediate adjusted earnings per share... More